Screener
BBH vs TMED
VanEck Biotech ETF vs T. Rowe Price Health Care ETF
Key differences
- BBH costs 0.09% less per year.
- BBH is significantly larger than TMED — larger funds tend to be more liquid and less likely to close.
- BBH covers north america markets; TMED covers global.
- BBH follows a index tracking strategy; TMED uses active selection.
- BBH has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| BBH | TMED | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.44% |
| Fund size (AUM) | $365M | $19M |
| Since | 2011 | 2025 |
| Dividend yield | 0.52% | — |
| Asset class | equity | equity |
| Region | north america | global |
| Strategy | index tracking | active selection |
| CAGR 1Y | +26.8% | N/A |
| CAGR 3Y | +5.9% | N/A |
| CAGR 5Y | +1.2% | N/A |
| Sharpe 3Y | 0.21 | N/A |
| Volatility 1Y | 18.82% | — |
| Max drawdown | -39.86% | -11.11% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to BBH and TMED
Explore further